Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Sojeong Yi"'
Autor:
Jaeseong Oh, Sojeong Yi, Namyi Gu, Dongseong Shin, Kyung-Sang Yu, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang
Publikováno v:
Genomics & Informatics, Vol 16, Iss 3, Pp 52-58 (2018)
In this report, we present a case study of how pharmacogenomics and pharmacometabolomics can be useful to characterize safety and pharmacokinetic profiles in early phase new drug development clinical trials. During conducting a first-in-human trial f
Externí odkaz:
https://doaj.org/article/c9749d02326f4c43a99c73c9afd57778
Publikováno v:
Therapeutic Innovation & Regulatory Science. 54:693-700
For topically applied over-the-counter (OTC) products, the association of unwanted systemic exposure and adverse events may be difficult to ascertain without a recognition or determination of in vivo absorption. Evaluation of skin permeability using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50333289df2c9bf893922881885c7be
https://doi.org/10.1007/s43441-019-00104-3
https://doi.org/10.1007/s43441-019-00104-3
Autor:
Sumin Yoon1, Sojeong Yi1, Su-jin Rhee1, Hyun A Lee1, Yun Kim1, Kyung-Sang Yu1, Jae-Yong Chung2 jychung@snubh.org
Publikováno v:
Translational & Clinical Pharmacology. Sep2019, Vol. 27 Issue 3, p107-114. 8p.
Autor:
J. Meyer, Julie Beitz, Sojeong Yi, Michael Pacanowski, Sushanta Chakder, Lian Ma, Jenny Doan, Emmanuel Akinshola, Dina Zand, Jie Wang, Laura Lee Johnson, Kathleen Donohue
Publikováno v:
Journal of Inherited Metabolic Disease. 44:515-517
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d08b79e8bf243f1d83211eddf936a98f
https://doi.org/10.1002/jimd.12377
https://doi.org/10.1002/jimd.12377
Autor:
Cheng-Hui Hsiao, Vikram Patel, Insook Kim, Liang Zhao, David G. Strauss, Murali K. Matta, Rodney Rouse, Miyoung Yoon, Ryan DePalma, Victoria Gershuny, Jeffry Florian, Robbert Zusterzeel, David A. Keire, Kristin W. Prentice, Sojeong Yi, Colleen Gosa Nalepinski, Joyce Korvick, Susan Selaya
Publikováno v:
JAMA
Importance In 2019, the US Food and Drug Administration (FDA) received a citizen petition indicating that ranitidine contained the probable human carcinogenN-nitrosodimethylamine (NDMA). In addition, the petitioner proposed that ranitidine could conv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be9eb6bd3dfc944b4be6ead6e65ed31e
https://pubmed.ncbi.nlm.nih.gov/34180953
https://pubmed.ncbi.nlm.nih.gov/34180953
Autor:
In-Gwon Kim, Seonmi Hong, Sojeong Yim, Jang-Hun Jeong, Kyunghi Choi, Ju-Hee Lee, Young-Seoub Hong, Sang-Yong Eom, Heon Kim, Yong-Dae Kim
Publikováno v:
Atmosphere, Vol 15, Iss 10, p 1157 (2024)
High blood pressure (BP) is a significant risk factor for heart and brain diseases. Previous studies have suggested that heavy metals including lead (Pb), mercury (Hg), and cadmium (Cd) contribute to hypertension. This study examined the combined eff
Externí odkaz:
https://doaj.org/article/42d8c89ee806427bbfc9427ffd5c6594
Autor:
Sojeong Yi, Dongseong Shin, In-Jin Jang, Jaeseong Oh, Seo Hyun Yoon, Joo Youn Cho, Namyi Gu, Kyung Sang Yu
Publikováno v:
Genomics & Informatics
Genomics & Informatics, Vol 16, Iss 3, Pp 52-58 (2018)
Genomics & Informatics, Vol 16, Iss 3, Pp 52-58 (2018)
In this report, we present a case study of how pharmacogenomics and pharmacometabolomics can be useful to characterize safety and pharmacokinetic profiles in early phase new drug development clinical trials. During conducting a first-in-human trial f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed9b65d56e93d0417911f9716d3720ed
http://europepmc.org/articles/PMC6187817
http://europepmc.org/articles/PMC6187817
Autor:
H. M. Byun, Sumin Yoon, Kyung Sang Yu, Jang Ij, Howard Lee, Jai Young Cho, Sojeong Yi, S. B. Jang
Publikováno v:
Alimentary Pharmacology & Therapeutics. 46:337-346
SummaryBackground YH4808, a K+-competitive acid blocker, is under clinical development for the treatment of acid-related disorders, such as gastroesophageal reflux disease. Aims We aimed to determine the safety, tolerability, pharmacokinetics (PK), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc0db33e2145981c88c0465e989e7cf7
https://doi.org/10.1111/apt.14148
https://doi.org/10.1111/apt.14148
Autor:
Kyung Sang Yu, Seo Hyun Yoon, Joo Youn Cho, Mi Young Bahng, Sojeong Yi, Dongseong Shin, In-Jin Jang, Seung-Hwan Lee
Publikováno v:
Drug Design, Development and Therapy
Dongseong Shin,1 SeungHwan Lee,2 Sojeong Yi,2 Seo Hyun Yoon,2 Joo-Youn Cho,2 Mi Young Bahng,3 In-Jin Jang,2 Kyung-Sang Yu2 1Clinical Trials Center, Gachon University Gil Medical Center, Incheon, 2Department of Clinical Pharmacology and Therapeutics,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec6392520b19c2258a8189888c55c81
http://europepmc.org/articles/PMC5354528
http://europepmc.org/articles/PMC5354528
Autor:
Jin-Tae Kim, Hee-Soo Kim, Sojeong Yi, Hyeong-Seok Lim, Joo Youn Cho, Eun Hee Kim, Ji Hyun Lee, In-Kyung Song, Min-Chang Kim
Publikováno v:
Journal of Clinical Medicine
Volume 8
Issue 10
Journal of Clinical Medicine, Vol 8, Iss 10, p 1563 (2019)
Volume 8
Issue 10
Journal of Clinical Medicine, Vol 8, Iss 10, p 1563 (2019)
Dexmedetomidine is a selective alpha-2 adrenergic agonist with concurrent sedative and analgesic effects, and it is being increasingly used in pediatric anesthesia and intensive care. This study aimed to investigate the pharmacokinetics of intravenou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad49334a8b2b27d8a0104139fd6ea065